华西医学

华西医学

关节假体感染的预防

查看全文

对于老龄人群、骨骼肌肉病变患者,关节置换术可有效提高生活质量、缓解疼痛,现已成为骨科常规手术。然而关节置换术后若发生关节假体感染(prosthetic joint infection,PJI),其后果往往是灾难性的。PJI 虽然发病率不高,但患者人群基数巨大,由此带来的患者生活质量下降和卫生经济负担巨大。该文从 PJI 的临床流行病学、诊断定义、发病机制、微生物学特点、发病风险因素几个方面,结合近期发表的手术部位感染预防控制指南,针对 PJI 的预防措施进行解读。

It has been certificated that hip and knee arthroplasty improving quality of life and relieving pain and discomfort for ageing population and patients with muscloskeletal disorders. However, the outcomes of prosthetic joint infections (PJI) after arthroplasty usually are disastrous. The incidence of PJI is lower, but the number of this population is huge, which makes the strong impacts on quality of life for patients and healthcare economics. This review discusses the prevention strategies of PJI based on clinical epidemiology, diagnostic definition, pathogenesis, microbiology and risk factors, combined with some guidelines for prevention surgical site infections published recently.

关键词: 关节假体感染; 手术部位感染; 预防

Key words: Prosthetic joint infection; Surgical site infection; Prevention

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Zmistowski B, Karam JA, Durinka JB, et al. Periprosthetic joint infection increases the risk of one-year mortality. J Bone Joint Surg Am, 2013, 95(24): 2177-2184.
2. Charnley J. Arthroplasty of the hip. A new operation. Lancet, 1961, 1(7187): 1129-1132.
3. Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am, 2007, 89(4): 780-785.
4. Jafari SM, Coyle C, Mortazavi S, et al. Revision hip arthroplasty infection is the most common cause of failure. Clin Orthop Relat Res, 2010, 468(8): 2046-2051.
5. Bozic KJ, Berry D, Parvizi J, et al. Prosthetic joint infection risk after TKA in the medicare population. Clin Orthop Relat Res, 2010, 468(1): 52-56.
6. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am, 2005, 87(8): 1746-1751.
7. Klouche S, Sariali E, Mamoudy P. Total hip arthroplasty revision due to infection: a cost analysis approach. Orthop Traumatol Surg Res, 2010, 96(2): 124-132.
8. Bozic KJ, Kurtz SM, Lau E, et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res, 2010, 468(1): 45-51.
9. Toulson C, Walcott-Sapp S, Hur J, et al. Treatment of infected total hip arthroplasty with a 2-Stage reimplantation protocol update on " our institution’s” experience from 1989 to 2003. J Arthroplasty, 2009, 24(7): 1051-1060.
10. Berend KR, Lombardi AV, Morris MJ, et al. Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality. Clin Orthop Relat Res, 2013, 471(2): 510-518.
11. Coello R, Charlett A, Wilson J, et al. Adverse impact of surgical site infections in English hospitals. J Hosp Infect, 2005, 60(2): 93-103.
12. Public Health England. Protocol for the surveillance of surgical site infection. Version 6[June 2013] r1. (2017-07-28)[2019-01-01] . https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/633775/surgical_site_infections_protocol_version_6.pdf.
13. Ong KL, Kurtz SM, Lau E, et al. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty, 2009, 24(6 Suppl): 105-109.
14. Kurtz SM, Ong KL, Lau E, et al. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res, 2010, 468(1): 52-56.
15. Tsaras G, Osmon DR, Mabry T, et al. Incidence, secular trends, and outcomes of prosthetic joint infection: a population-based study, olmsted county, Minnesota, 1969-2007. Infect Control Hosp Epidemiol, 2012, 33(12): 1207-1212.
16. Kurtz SM, Lau E, Watson H, et al. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty, 2012, 27(8 Suppl): 61-65.e1.
17. Malpiedi PJ, Peterson KD, Soe MM, et al. 2011 National and state healthcare-associated infection standardized infection ratio report. (2013-02-11)[2019-01-01]. http://www.cdc.gov/hai/national-annual-sir/index.html.
18. European Centre for Disease Prevention and Control. Surveillance of surgical site infection in Europe, 2008-2009. Stockholm: ECDC, 2012.
19. 赵明明, 任磊, 刘卫兵, 等. 人工关节置换术切口感染因素调查. 中国消毒学杂志, 2014, 31(12): 1339-1340.
20. 吴建浓, 干铁儿, 周亚芬, 等. 人工关节置换术患者术后医院感染危险因素分析. 中华医院感染学杂志, 2014, 24(21): 5357-5359.
21. 南玲, 刘丁, 黄庆宁, 等. 人工关节置换手术部位感染发病率及危险因素分析. 中国消毒学杂志, 2017, 34(7): 664-666.
22. Parvizi J, Della Valle CJ. AAOS clinical practice guideline: diagnosis and treatment of periprosthetic joint infections of the hip and knee. J Am Acad Orthop Surg, 2010, 18(12): 771-772.
23. Parvizi J, Zmistowski B, Berbari EF, et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res, 2011, 469(11): 2992-2994.
24. Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis, 2013, 56(1): e1-e25.
25. Parvizi J. New definition for periprosthetic joint infection. Am J Orthop (Belle Mead NJ), 2011, 40(12): 614-615.
26. Parvizi J, Tan TL, Goswami K, et al. The 2018 Definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J Arthroplasty, 2018, 33(5): 1309-1314.
27. Parvizi J, Gehrke T, Chen AF. Proceedings of the international consensus on periprosthetic joint infection. Bone Joint J, 2013, 95-B(11): 1450-1452.
28. Atkins GJ, Alberdi MT, Beswick AA, et al. General Assembly, prevention, surgical site preparation: proceedings of international consensus on orthopedic infections. J Arthroplasty, 2019, 34(2, S): S85-S92.
29. Hozack WJ, Parvizi J. New definition for periprosthetic joint infection. J Arthroplasty, 2011, 26(8): 1135.
30. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med, 2004, 351(16): 1645-1654.
31. Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest, 1984, 73(4): 1191-1200.
32. Tande AJ, Gomez-Urena EO, Berbari EF, et al. Management of prosthetic joint infection. Infect Dis Clin North Am, 2017, 31(2): 237-252.
33. Parvizi J, Gehrke T, International Consensus Group on Periprosthetic Joint Infection. Definition of periprosthetic joint infection. J Arthroplasty, 2014, 29(7): 1331.
34. Beam E, Osmon D. Prosthetic joint infection update. Infect Dis Clin North Am, 2018, 32(4): 843-859.
35. Bedair H, Ting N, Jacovides C, et al. The mark coventry award: diagnosis of early postoperative TKA infection using synovial fluid analysis. Clin Orthop Relat Res, 2011, 469(1): 34-40.
36. Cobo F, Rodriguez-Granger J, Lopez EM, et al. Candida-induced prosthetic joint infection. A literature review including 72 cases and a case report. Infect Dis (Lond), 2017, 49(2): 81-94.
37. Carrega G, Bartolacci V, Burastero G, et al. Prosthetic joint infections due to Mycobacterium tuberculosis: a report of 5 cases. Int J Surg Case Rep, 2013, 4(2): 178-181.
38. Su JY, Huang TL, Lin SY. Total knee arthroplasty in tuberculous arthritis. Clin Orthop Relat Res, 1996(323): 181-187.
39. Gomez E, Chiang T, Louie T, et al. Prosthetic joint infection due to mycobacterium bovis after intravesical instillation of bacillus Calmette-Guerin (BCG). Int J Microbiol, 2009, 2009: 527208.
40. Berbari EF, Marculescu C, Sia I, et al. Culture-negative prosthetic joint infection. Clin Infect Dis, 2007, 45(9): 1113-1119.
41. Chirca I, Marculescu C. Prevention of infection in orthopedic prosthetic surgery. Infect Dis Clin North Am, 2017, 31(2): 253-263.
42. Pruzansky JS, Bronson MJ, Grelsamer RP, et al. Prevalence of modifiable surgical site infection risk factors in hip and knee joint arthroplasty patients at an urban academic hospital. J Arthroplasty, 2014, 29(2): 272-276.
43. Namba RS, Inacio M, Paxton EW. Risk factors associated with surgical site infection in 30491 primary total hip replacements. J Bone Joint Surg Br, 2012, 94(10): 1330-1338.
44. Dowsey MM, Choong PF. Obese diabetic patients are at substantial risk for deep infection after primary TKA. Clin Orthop Relat Res, 2009, 467(6): 1577-1581.
45. Peel TN, Dowsey MM, Daffy JR, et al. Risk factors for prosthetic hip and knee infections according to arthroplasty site. J Hosp Infect, 2011, 79(2): 129-133.
46. Liabaud B, Patrick DJ, Geller JA. Higher body mass index leads to longer operative time in total knee arthroplasty. J Arthroplasty, 2013, 28(4): 563-565.
47. Teo BJ, Yeo W, Chong HC, et al. Surgical site infection after primary total knee arthroplasty is associated with a longer duration of surgery. J Orthop Surg (Hong Kong), 2018, 26(2): 614445935.
48. Namba RS, Inacio MC, Paxton EW. Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees. J Bone Joint Surg Am, 2013, 95(9): 775-782.
49. Berbari EF, Osmon DR, Lahr B, et al. The Mayo prosthetic joint infection risk score: implication for surgical site infection reporting and risk stratification. Infect Control Hosp Epidemiol, 2012, 33(8): 774-781.
50. Yi PH, Frank RM, Vann E, et al. Is potential malnutrition associated with septic failure and acute infection after revision total joint arthroplasty?. Clin Orthop Relat Res, 2015, 473(1): 175-182.
51. Mraovic B, Suh D, Jacovides C, et al. Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty. J Diabetes Sci Technol, 2011, 5(2): 412-418.
52. Jamsen E, Nevalainen PI, Eskelinen AA, et al. Risk factors for perioperative hyperglycemia in primary hip and knee replacements. Acta Orthop, 2015, 86(2): 175-182.
53. American Diabetes Association. Standards of medical care in diabetes-2016: summary of revisions. Diabetes Care, 2016, 39(Suppl 1): S4-S5.
54. Singh JA. Smoking and outcomes after knee and hip arthroplasty: a systematic review. J Rheumatol, 2011, 38(9): 1824-1834.
55. Alexander JW, Solomkin JS, Edwards MJ. Updated recommendations for control of surgical site infections. Ann Surg, 2011, 253(6): 1082-1093.
56. Keely BK, Rachala S, Nodzo SR. Centers for disease control and prevention 2017 guidelines for prevention of surgical site infections: review and relevant recommendations. Curr Rev Musculoskelet Med, 2018, 11(3): 357-369.
57. Momohara S, Kawakami K, Iwamoto T, et al. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheumatol, 2011, 21(5): 469-475.
58. World Health Organization. Global guidelines for the prevention of surgical site infection. Geneva: World Health Organization, 2018.
59. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg, 2017, 152(8): 784-791.
60. Hacek DM, Robb WJ, Paule SM, et al. Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res, 2008, 466(6): 1349-1355.
61. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PA, et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis, 2002, 35(4): 353-358.
62. Hochberg MC, Altman RD, April KT, et al. American college of rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken), 2012, 64(4): 465-474.
63. Brown GA. AAOS clinical practice guideline on treatment of osteoarthritis of the knee: evidence-based guideline, 2nd. J Am Acad Orthop Surg, 2013, 21(9): 577-579.
64. Siegel JD, Rhinehart E, Jackson MA, et al. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control, 2007, 35(10 Suppl2): S65-S164.
65. Bedard NA, Pugely AJ, Elkins JM, et al. The john N. insall award do intraarticular injections increase the risk of infection after TKA?. Clin Orthop Relat Res, 2017, 475(1): 45-52.
66. Chambers AW, Lacy KW, Liow MH, et al. Multiple hip intra-articular steroid injections increase risk of periprosthetic joint infection compared with single injections. J Arthroplasty, 2017, 32(6): 1980-1983.
67. Schairer WW, Nwachukwu BU, Mayman DJ, et al. Preoperative hip injections increase the rate of periprosthetic infection after total hip arthroplasty. J Arthroplasty, 2016, 31(9 Suppl): S166-S169.
68. Mcintosh AL, Hanssen AD, Wenger DE, et al. Recent intraarticular steroid injection may increase infection rates in primary THA. Clin Orthop Relat Res, 2006(451): 50-54.
69. Brown GA. AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg, 2013, 21(9): 577-579.
70. Ruyssen-Witrand A, Fautrel B, Saraux AA, et al. Infections induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review. Joint Bone Spine, 2010, 77(3): 246-251.
71. Goodman SM, Springer B, Guyatt G, et al. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. J Arthroplasty, 2017, 32(9): 2628-2638.
72. Thompson BM, Stearns JD, Apsey HA, et al. Perioperative management of patients with diabetes and hyperglycemia undergoing elective surgery. Curr Diab Rep, 2016, 16(1): 2.
73. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm, 2013, 70(3): 195-283.
74. Sewick A, Makani A, Wu C, et al. Does dual antibiotic prophylaxis better prevent surgical site infections in total joint arthroplasty?. Clin Orthop Relat Res, 2012, 470(10): 2702-2707.
75. Parvizi J, Saleh KJ, Ragland PS, et al. Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop, 2008, 79(3): 335-341.
76. van Kasteren ME, Manniën J, Ott A, et al. Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. Clin Infect Dis, 2007, 44(7): 921-927.
77. Creighton MG, Callaghan JJ, Olejniczak JP, et al. Total hip arthroplasty with cement in patients who have rheumatoid arthritis. A minimum ten-year follow-up study. J Bone Joint Surg (Am), 1998, 80-A: 1439-1446.
78. Evans RP. Current concepts for clean air and total joint arthroplasty: laminar airflow and ultraviolet radiation: a systematic review. Clin Orthop Relat Res, 2011, 469(4): 945-953.
79. Charnley J. Postoperative infection after total hip replacement with special reference to air contamination in the operating room. Clin Orthop Relat Res, 1972, 87: 167-187.
80. Tayton ER, Frampton C, Hooper GJ, et al. The impact of patient and surgical factors on the rate of infection after primary total knee arthroplasty. An analysis of 64566 joints from the New Zealand Joint Registry. Bone Joint J, 2016, 98B(3): 334-340.
81. Kim JL, Park JH, Han SB, et al. Allogeneic blood transfusion is a significant risk factor for surgical-site infection following total hip and knee arthroplasty: a meta-analysis. J Arthroplasty, 2017, 32(1): 320-325.
82. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med, 2012, 157(1): 49-58.
83. Cooper HJ, Bas MA. Closed-incision negative-pressure therapy versus antimicrobial dressings after revision hip and knee surgery: a comparative study. J Arthroplasty, 2016, 31(5): 1047-1052.